Benzo[a]pyrene diol epoxide suppresses retinoic acid receptor-β2 expression by recruiting DNA (cytosine-5-)-methyltransferase 3A

Molecular Cancer

Volumn 9, Issue , 2010, Pages

  Ye, Fei ^a   Xu, Xiao Chun ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CYCLOOXYGENASE 2; DIHYDROXYBENZO[A]PYRENE OXIDE; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN C JUN; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR BETA2; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; BENZO[A]PYRENE 7,8 DIHYDRODIOL 9,10 OXIDE; CARCINOGEN; DNA (CYTOSINE 5) METHYLTRANSFERASE; RETINOIC ACID RECEPTOR;

ARTICLE; CANCER CELL; CARCINOGENESIS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA METHYLATION; DRUG MECHANISM; DRUG PROTEIN BINDING; ESOPHAGUS CANCER; GENE EXPRESSION REGULATION; GENE REPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA VECTOR; BIOSYNTHESIS; DRUG EFFECT; ESOPHAGUS TUMOR; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; METABOLISM; NORTHERN BLOTTING; TUMOR CELL LINE; WESTERN BLOTTING;

NICOTIANA TABACUM;

7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; BLOTTING, NORTHERN; BLOTTING, WESTERN; CARCINOGENS; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION; HUMANS; PROMOTER REGIONS, GENETIC; RECEPTORS, RETINOIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 77951566128     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-9-93     Document Type: Article

References (36)

1. Osborne MR, Crosby NT. Benzopyrenes 1987, Cambridge, UK: Cambridge University Press.
2. Hoffmann D, Hecht SS. Advances in tobacco carcinogenesis. Chemical Carcinogenesis and Mutagenesis I. Handbook of Experimental Pharmacology 1990, 94:63-102. Berlin, Germany: Springer-Verlag, Cooper CS, Grover PL.
3. Harvey RG. Polycyclic Aromatic Hydrocarbons: Chemistry and Carcinogenesis 1991, Cambridge, UK: Cambridge University Press.
4. Hecht SS. Cigarette smoking: cancer risks, carcinogens, and mechanisms. Langenbecks Arch Surg 2006, 391:603-613. 10.1007/s00423-006-0111-z, 17031696.
5. Smoking, Tobacco, Cancer Program (U.S.) Smoking, Tobacco, and Cancer Program: 1985-1989 Status Report 1990, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute. NIH Publication No. 90-3107. Bethesda, MD, Smoking, Tobacco, Cancer Program (U.S.).
6. Zhang ZF, Kurtz RC, Sun M, Karpeh M, Yu GP, Gargon N, Fein JS, Georgopoulos SK, Harlap S. Adenocarcinomas of the esophagus and gastric cardia: medical conditions, tobacco, alcohol, and socioeconomic factors. Cancer Epidemiol Biomarkers Prev 1996, 5:761-768.
7. Gammon MD, Schoenberg JB, Ahsan H, Risch HA, Vaughan TL, Chow WH, Rotterdam H, West AB, Dubrow R, Stanford JL, Mayne ST, Farrow DC, Niwa S, Blot WJ, Fraumeni JF. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1997, 89:1277-1284. 10.1093/jnci/89.17.1277, 9293918.
8. Tran GD, Sun XD, Abnet CC, Fan JH, Dawsey SM, Dong ZW, Mark SD, Qiao YL, Taylor PR. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer 2005, 113:456-463. 10.1002/ijc.20616, 15455378.
9. Xu X-C. Risk factors and gene expression in esophageal cancer. Cancer Epidemiology, Host Susceptibility Factors 2009, I:335-360. New York: Humana Press, Verma M.
10. Venkatachalam S, Denissenko MF, Alvi N, Wani AA. Rapid activation of apoptosis in human promyelocytic leukemic cells by (+/-)-anti-benzo[a]pyrene diol epoxide induced DNA damage. Biochem Biophys Res Commun 1993, 197:722-729. 10.1006/bbrc.1993.2539, 8267608.
11. Denissenko MF, Pao A, Tang M, Pfeifer GP. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science 1996, 274:430-432. 10.1126/science.274.5286.430, 8832894.
12. Wang D, You L, Sneddon J, Cheng SL, Jamasbi R, Stoner GD. Frameshift mutation in codon 176 of the p53 gene in rat esophageal epithelial cells transformed by benzo[a]pyrene dihydrodiol. Mol Carcinog 1995, 14:84-93. 10.1002/mc.2940140204, 7576103.
13. Mass MJ, Jeffers AJ, Ross JA, Nelson G, Galati AJ, Stoner GD, Nesnow S. Ki-ras oncogene mutations in tumors and DNA adducts formed by benz[j]aceanthrylene and benzo[a]pyrene in the lungs of strain A/J mice. Mol Carcinog 1993, 8:186-192. 10.1002/mc.2940080309, 8216737.
14. Liang Z, Lippman SM, Kawabe A, Shimada Y, Xu X-C. Identification of benzo[a]pyrene diol epoxide-binding DNA fragments using DNA-immunoprecipitation technique. Cancer Res 2003, 63:1470-1474.
15. Wang XD, Liu C, Bronson RT, Smith DE, Krinsky NI, Russell M. Retinoid signaling and activator protein-1 expression in ferrets given beta-carotene supplements and exposed to tobacco smoke. J Natl Cancer Inst 1999, 91:60-66. 10.1093/jnci/91.1.60, 9890171.
16. Vuillemenot BR, Pulling LC, Palmisano WA, Hutt JA, Belinsky SA. Carcinogen exposure differentially modulates RAR-beta promoter hypermethylation, an early and frequent event in mouse lung carcinogenesis. Carcinogenesis 2004, 25:623-629. 10.1093/carcin/bgh038, 14656941.
17. Song S, Xu XC. Effect of benzo[a]pyrene diol epoxide on expression of retinoic acid receptor-beta in immortalized esophageal epithelial cells and esophageal cancer cells. Biochem Biophys Res Commun 2001, 281:872-877. 10.1006/bbrc.2001.4433, 11237740.
18. Li M, Song S, Lippman SM, Zhang XK, Liu X, Lotan R, Xu XC. Induction of retinoic acid receptor-β suppresses cyclooxygenase-2 expression in esophageal cancer cells. Oncogene 2002, 21:411-418. 10.1038/sj.onc.1205106, 11821953.
19. Song S, Lippman SM, Zou Y, Ye X, Ajani JA, Xu X-C. Induction of cyclooxygenase-2 by benzo[a]pyrene diol epoxide through inhibition of retinoic acid receptor-β2 expression. Oncogene 2005, 24:8268-8276. 10.1038/sj.onc.1208992, 16170369.
20. Soprano DR, Qin P, Soprano KJ. Retinoic acid receptors and cancers. Annu Rev Nutr 2004, 24:201-221. 10.1146/annurev.nutr.24.012003.132407, 15189119.
21. Xu X-C. Tumor-suppressive activity of RAR-β2 in cancer. Cancer Lett 2007, 253:14-24. 10.1016/j.canlet.2006.11.019, 2562790, 17188427.
22. Mongan NP, Gudas LJ. Diverse actions of retinoid receptors in cancer prevention and treatment. Differentiation 2007, 75:853-870. 10.1111/j.1432-0436.2007.00206.x, 17634071.
23. Bean GR, Scott V, Yee L, Ratliff-Daniel B, Troch MM, Seo P, Bowie ML, Marcom PK, Slade J, Kimler BF, Fabian CJ, Zalles CM, Broadwater G, Baker JC, Wilke LG, Seewaldt VL. Retinoic acid receptor-β2 promoter methylation in random periareolar fine needle aspiration. Cancer Epidemiol Biomarkers Prev 2005, 14:790-798. 10.1158/1055-9965.EPI-04-0580, 15824145.
24. Grote HJ, Schmiemann V, Geddert H, Rohr UP, Kappes R, Gabbert HE, Bocking A. Aberrant promoter methylation of p16(INK4a), RAR-β2 and SEMA3B in bronchial aspirates from patients with suspected lung cancer. Int J Cancer 2005, 116:720-725. 10.1002/ijc.21090, 15849750.
25. Wang Y, Fang MZ, Liao J, Yang GY, Nie Y, Song Y, So C, Xu X-C, Wang LD, Yang CS. Hypermethylation-associated inactivation of retinoic acid receptor beta in human esophageal squamous cell carcinoma. Clin Cancer Res 2003, 9:5257-5263.
26. Li R, Saito T, Tanaka R, Satohisa S, Adachi K, Horie M, Akashi Y, Kudo R. Hypermethylation in promoter region of retinoic acid receptor-beta gene and immunohistochemical findings on retinoic acid receptors in carcinogenesis of endometrium. Cancer Lett 2005, 219:33-40. 10.1016/j.canlet.2004.06.044, 15694662.
27. Olasz J, Juhasz A, Remenar E, Engi H, Bak M, Csuka O, Kasler M. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age. Oncol Report 2007, 18:105-112.
28. Jiang Y, Liang ZD, Wu TT, Cao L, Zhang H, Xu X-C. ATM expression is associated with tobacco smoke exposure in esophageal cancer tissues and benzo[a]pyrene diol epoxide in cell lines. Int J Cancer 2007, 120:91-95. 10.1002/ijc.22121, 17019709.
29. Liu H, Zhou Y, Boggs SE, Belinsky SA, Liu J. Cigarette smoke induces demethylation of prometastatic oncogene synuclein-c in lung cancer cells by downregulation of DNMT3B. Oncogene 2007, 26:5900-5910. 10.1038/sj.onc.1210400, 17369845.
30. Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, Lu H, Yang CS. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 2003, 63:7563-7570.
31. Issa JP. CpG island methylator phenotype in cancer. Nat Rev Cancer 2004, 4:988-993. 10.1038/nrc1507, 15573120.
32. Di Croce L, Raker VA, Corsaro M, Fazi F, Fanelli M, Faretta M, Fuks F, Lo Coco F, Kouzarides T, Nervi C, Minucci S, Pelicci PG. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 2002, 295:1079-1082. 10.1126/science.1065173, 11834837.
33. Lin RK, Hsieh YS, Lin P, Hsu HS, Chen CY, Tang YA, Lee CF, Wang YC. The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients. J Clin Invest 2010, 120:521-532. 2810088, 20093774.
34. Breton CV, Byun HM, Wenten M, Pan F, Yang A, Gilliland FD. Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation. Am J Respirat Crit Care Med 2009, 180:462-467.
35. Oka D, Yamashita S, Tomioka T, Nakanishi Y, Kato H, Kaminishi M, Ushijima T. The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history: a target for risk diagnosis and prevention of esophageal cancers. Cancer 2009, 115:3412-3426. 10.1002/cncr.24394, 19472401.
36. Xu XC, Liu X, Tahara E, Lippman SM, Lotan R. Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines. Cancer Res 1999, 59:2477-2483.